Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jul;37(7):875-880.
doi: 10.1038/jp.2017.41. Epub 2017 Apr 6.

Long-term outcomes of children with symptomatic congenital cytomegalovirus disease

T M Lanzieri  1 , J Leung  1 , A C Caviness  2 , W Chung  3 , M Flores  2 , P Blum  4 , S R Bialek  1 , J A Miller  4   5 , S S Vinson  2   4 , M R Turcich  2   4 , R G Voigt  2   4 , G Demmler-Harrison  2   4
Affiliations

Long-term outcomes of children with symptomatic congenital cytomegalovirus disease

T M Lanzieri et al. J Perinatol. 2017 Jul.

Abstract

Objective: To assess long-term outcomes of children with symptomatic congenital cytomegalovirus (CMV) disease detected at birth.

Study design: We used Cox regression to assess risk factors for intellectual disability (intelligence quotient <70), sensorineural hearing loss (SNHL; hearing level ⩾25 dB in any audiometric frequency) and vision impairment (best corrected visual acuity >20 or based on ophthalmologist report).

Results: Among 76 case-patients followed through median age of 13 (range: 0-27) years, 56 (74%) had SNHL, 31 (43%, n=72) had intellectual disability and 18 (27%, n=66) had vision impairment; 28 (43%, n=65) had intellectual disability and SNHL with/without vision impairment. Microcephaly was significantly associated with each of the three outcomes. Tissue destruction and dysplastic growth on head computed tomography scan at birth was significantly associated with intellectual disability and SNHL.

Conclusion: Infants with symptomatic congenital CMV disease may develop moderate to severe impairments that were associated with presence of microcephaly and brain abnormalities.

PubMed Disclaimer

Conflict of interest statement

Potential Conflict of Interest: Dr. Demmler-Harrison’s institution received funding from Merck Sharpe & Dohme Corporation since July 2016 to assist with salary support for further analysis on long term outcomes of congenital CMV infection not included in this report. The other authors have no potential conflicts to disclose.

References

    1. Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol. 2007;17(5):355–363. - PubMed
    1. Boppana SB, Ross SA, Shimamura M, Palmer AL, Ahmed A, Michaels MG, et al. Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns. N Engl J Med. 2011;364(22):2111–2118. - PMC - PubMed
    1. Boppana SB, Ross SA, Novak Z, Shimamura M, Tolan RW, Jr, Palmer AL, et al. Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection. JAMA. 2010;303(14):1375–1382. - PMC - PubMed
    1. Ahlfors K, Ivarsson SA, Harris S. Report on a long-term study of maternal and congenital cytomegalovirus infection in Sweden. Review of prospective studies available in the literature. Scand J Infect Dis. 1999;31(5):443–457. - PubMed
    1. Boppana SB, Fowler KB, Britt WJ, Stagno S, Pass RF. Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus. Pediatrics. 1999;104(1 Pt 1):55–60. - PubMed

Publication types

MeSH terms